Helping Cancer Patients with Chronic Pain
Creating Ethical Shareholder Value

Welcome to the CBD Science Investor Portal

Dr. Michael Raymont


Mike’s depth of experience in entrepreneurship, venture capital and government relations is evident by his past leadership of AVAC, Canada’s largest Agri-Tech venture capital fund and acting president of National Research Council.

Barney Neal


Barney is a product & marketing entrepreneur focussing his efforts to enable access to life changing plant medicines for patients in need. Barney has worked closely with the Conscious Fund, a Venture Capital Fund focused on cannabis & psychedelics.

Graeme McFarlane


30+ years in the pharmaceutical industry holding senior management positions in Astra Zenca, GlaxoSmithKline and Bristol Myers before starting B2B companies specializing in Pharma Market Access, his most recent having been sold to IQVIA.

Rob Kang


25+ years of public practice and company management advising corporations and their executives on financing, mergers and acquisitions, going public transaction, continuous disclosure obligations, and corporate governance.

Still want to know more?

Updated on August 30, 2021